Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$17.75 - $41.6 $29,465 - $69,056
1,660 Added 5.33%
32,823 $1.3 Million
Q4 2023

Feb 13, 2024

BUY
$8.54 - $20.22 $61,231 - $144,977
7,170 Added 29.88%
31,163 $593,000
Q3 2023

Nov 14, 2023

BUY
$10.13 - $13.98 $136,086 - $187,807
13,434 Added 127.23%
23,993 $274,000
Q2 2023

Aug 21, 2023

BUY
$6.84 - $11.91 $12,058 - $20,997
1,763 Added 20.04%
10,559 $108,000
Q1 2023

May 09, 2023

SELL
$7.0 - $8.75 $1,694 - $2,117
-242 Reduced 2.68%
8,796 $67,000
Q4 2022

Feb 14, 2023

BUY
$5.45 - $7.35 $15,657 - $21,116
2,873 Added 46.6%
9,038 $66,000
Q3 2022

Nov 18, 2022

SELL
$6.89 - $9.39 $3,541 - $4,826
-514 Reduced 7.7%
6,165 $44,000
Q2 2022

Aug 15, 2022

BUY
$6.71 - $9.52 $11,487 - $16,298
1,712 Added 34.47%
6,679 $57,000
Q1 2022

May 16, 2022

SELL
$6.41 - $13.89 $7,583 - $16,431
-1,183 Reduced 19.24%
4,967 $45,000
Q4 2021

Feb 15, 2022

SELL
$10.41 - $13.95 $676 - $906
-65 Reduced 1.05%
6,150 $85,000
Q3 2021

Nov 15, 2021

SELL
$8.19 - $11.31 $81,261 - $112,217
-9,922 Reduced 61.49%
6,215 $66,000
Q2 2021

Aug 16, 2021

BUY
$8.81 - $15.03 $142,166 - $242,539
16,137 New
16,137 $145,000

Others Institutions Holding ALPN

About ALPINE IMMUNE SCIENCES, INC.


  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.